Potential coeliac disease in Type 1 diabetes mellitus: Does a positive antibody lead to increased complications?

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 4, 2014, Pages 378-383

  Leeds, J S ^a   Hopper, A D ^a   Hadjivassiliou, M ^a   Tesfaye, S ^a   Sanders, D S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

BMI; CASE; CD; Coeliac disease; Complications; DAFNE; GFD; Glycaemic control; HbA1c; HDL; IgA; Type 1 diabetes

Indexed keywords

CHOLESTEROL; ENDOMYSIUM ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIBODY; BIOLOGICAL MARKER; CREATININE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD PRESSURE; CELIAC DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; ENTEROPATHY; FEMALE; GLYCEMIC CONTROL; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MIDDLE AGED; NERVE CONDUCTION; PERIPHERAL NERVE; PRIORITY JOURNAL; YOUNG ADULT; BIOPSY; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHIES; DUODENUM; IMMUNOLOGY; PATHOLOGY; PILOT STUDY; PREDICTIVE VALUE; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; CELIAC DISEASE; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DUODENUM; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84897906370     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.09.005     Document Type: Article

References (23)

1. Page S.R., Lloyd C.A., Hill P.G., Peacock I., Holmes G.K.T. The prevalence of coeliac disease in adult diabetes mellitus. Q J Med 1994, 87:631-637.
2. De Vitis I., Ghirlanda G., Gasbarrini G. Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr Suppl 1996, 412:56-57.
3. Sjöberg K., Eriksson K.F., Brendberg A., Wassmuth R., Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998, 243:133-140.
4. Leeds J.S., Hopper A.D., Hadjivassiliou M., Tesfaye S., Sanders D.S. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 2011, 34(10):2158-2163.
5. Luostarinen L., Himanen S.L., Luostarinen M., Collin P., Pirttilä T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry 2003, 74:490-494.
6. Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., Davies-Jones G.A.B., Gibson A., Jarratt J.A., et al. Clinical, radiological, neurophysiological and neuropathological characteristics of gluten ataxia. Lancet 1998, 347:369-371.
7. Jackson J.R., Eaton W.W., Cascella N.G., Fasano A., Kelly D.L. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 2012, 83(1):91-102.
8. Ferguson A., Arranz E., O'Mahony S. Clinical and pathological spectrum of coeliac disease - active, silent, latent, potential. Gut 1993, 34:150-151.
9. Troncone R., Greco L., Mayer M., Paparo F., Caputo N., Micillo M., et al. Latent and potential coeliac disease. Acta Paediatr Suppl 1996, 412:10-14.
10. Troncone R., Franzese A., Mazzarella G., Paparo F., Auricchio R., Coto I., et al. Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus. Am J Gastroenterol 2003, 98(3):590-595.
11. Hadjivassiliou M., Davies-Jones G.A., Sanders D.S., Grunewald R.A. The dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 2003, 74:1221-1224.
12. Hadjivassiliou M., Boscolo S., Davies-Jones G.A., Grunewald R.A., Not T., Sanders D.S., et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002, 58:1221-1226.
13. Ludvigsson J.F., Montgomery S.M., Ekbom A., Brandt L., Granath F. Small-intestinal histopathology and mortality risk in celiac disease. J Am Med Assoc 2009, 302(11):1171-1178.
14. West J., Logan R.F., Card T.R., Smith C., Hubbard R. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther 2004, 20(1):73-79.
15. West J., Logan R.F., Hill P.G., Khaw K.T. The iceberg of celiac disease: what is below the waterline?. Clin Gastroenterol Hepatol 2007, 5(1):59-62.
16. Lewis N.R., Sanders D.S., Logan R.F., Fleming K.M., Hubbard R.B., West J. Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment. Br J Nutr 2009, 102(4):509-513.
17. Pitocco D., Giubilato S., Martini F., Zaccardi F., Pazzano V., Manto A., et al. Combined atherogenic effects of celiac disease and type 1 diabetes mellitus. Atherosclerosis 2011, 217(2):531-535.
18. American Diabetes Association Position Statement Diagnosis and classification of diabetes mellitus. Diabetes Care 2007, 30(Suppl. 1):S42-S47.
19. Oberhuber G., Granditsch G., Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999, 11:1185-1194.
20. Clements C., Prince C.B., Prasad S., Aralikatti S., Swindlehurst H., Clearkin L.G. National screening programme for diabetic retinopathy. BMJ 2002, 324:849.
21. Chin R.L., Sander H.W., Brannagan T.H., Green P.H., Hays A.P., Alaedini A., et al. Celiac neuropathy. Neurology 2003, 60(10):1581-1585.
22. Saibeni S., Lecchi A., Meucci G., Cattaneo M., Tagliabue L., Rondonotti E., et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 2005, 3(6):574-580.
23. Hadithi M., Mulder C.J., Stam F., Azizi J., Crusius J.B., Peña A.S., et al. Effect of B vitamin supplementation on plasma homocysteine levels in celiac disease. World J Gastroenterol 2009, 15(8):955-960.